AstraZeneca follows Merck with Phase 3 win in bladder cancer

May 14, 2026 10:31 AM EDT R&D As­traZeneca fol­lows Mer­ck with Phase 3 win in blad­der can­cer Elizabeth Cairns Senior biopharma journalist A com­bi­na­tion of As­traZeneca’s Imfinzi with Pfiz­er and Astel­las’ Pad­cev kept more blad­der can­cer pa­tients alive than stan­dard of care, the com­pa­ny said Thurs­day. As­traZeneca … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER